US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Axogen, Inc. - Common Stock (NQ:AXGN)

49.37 -0.26 (-0.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axogen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
Why Is Axogen Stock Down 11% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
News headline image
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday ↗
 
Via Benzinga
News headline image
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months ↗
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full-year revenue outlook. 
Via Benzinga
News headline image
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted ↗
The FDA's move is largely procedural, says one analyst, but it adds incremental uncertainty. 
Via Investor's Business Daily
News headline image
Which stocks are moving before the opening bell on Monday? ↗
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
FDA PDUFA goal date extended by three months 
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen (AXGN) Q2 Revenue Jumps 18% ↗
Via The Motley Fool
News headline image
Axogen Inc (NASDAQ:AXGN) Surges 15.8% After Q2 2025 Earnings Beat and Raised Guidance ↗
Axogen Inc (AXGN) surpasses Q2 2025 estimates with strong revenue and EPS growth, raises full-year guidance, sparking a 15.8% pre-market stock surge. 
Via Chartmill
Topics Earnings
News headline image
These stocks are moving in today's pre-market session ↗
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Axogen, Inc. Reports Second Quarter 2025 Financial Results
Raises Full Year Revenue Guidance to at Least 17% Growth or $219 Million 
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
From Axogen, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
News headline image
What Analysts Are Saying About Axogen Stock ↗
 
Via Benzinga
News headline image
Which stocks are gapping on Thursday? ↗
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
Axogen, Inc. Reports 2025 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen Announces Chief Financial Officer Transition
Lindsey Hartley, CPA, appointed as Chief Financial Officer to succeed Nir Naor 
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
From Axogen, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >